Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 13;38(1):BSR20171440.
doi: 10.1042/BSR20171440. Print 2018 Feb 28.

6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound

Affiliations
Review

6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound

Huan-Huan Sha et al. Biosci Rep. .

Abstract

The 7-nitro-2,1,3-nitrobenzoxadiazole (NBD) derivatives are a series of compounds containing the NBD scaffold that are not glutathione (GSH) peptidomimetics, and result in a strong inhibition of glutathione S-transferases (GSTs). Growing evidences highlight their pivotal roles and outstanding anticancer activity in different tumor models. In particular, 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol (NBDHEX) is extensively studied, which is a very efficient inhibitor of GSTP1-1. It triggers apoptosis in several tumor cell lines and this cytotoxic activity is observed at micro and submicromolar concentrations. Importantly, studies have shown that NBDHEX acts as an anticancer drug by inhibiting GSTs catalytic activity, avoiding inconvenience of the inhibitor extrusion from the cell by specific pumps and disrupting the interaction between the GSTP1-1 and key signaling effectors. Additionally, some researchers also have discovered that NBDHEX can act as late-phase autophagy inhibitor, which opens new opportunities to fully exploit its therapeutic potential. In this review, we summarize the advantages, anticancer mechanisms, and analogs of this compound, which will establish the basis on the usage of NBDHEX in clinical applications in future.

Keywords: GSTP1-1 (Glutathione S-transferase Pi); JNK (c-Jun N-Terminal Kinase); NBDHEX (6- (7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol); anticancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Structures of NBDHEX and its analogs
Figure 2
Figure 2. Proposed action mechanism of NBDHEX
NBDHEX causes the dissociation of both the GSTP1-1–TRAF2 and the GSTP1-1–JNK complexes and triggers the activation of the MAPK signaling pathway. It induces apoptosis and cell cycle arrest via the phospho-activation of JNK and p38 and their downstream targets including c-Jun, ATF2, and p53. Besides, JNK can participate in impairing autophagy. In addition, the possibility that NBDHEX directly activates p38 through the imbalance of the intracellular redox state cannot be excluded, in which case, cells died by necrosis.

References

    1. Tew K.D., et al. (1996) Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol. Pharmacol. 50, 149–159 - PubMed
    1. Ricci G., et al. (2005) 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs. J. Biol. Chem. 280, 26397–405 10.1074/jbc.M503295200 - DOI - PubMed
    1. Tew K.D., Dutta S. and Schultz M. (1997) Inhibitors of glutathione S-transferases as therapeutic agents. Adv. Drug. Deliv. Rev. 26, 91–104 10.1016/S0169-409X(97)00029-X - DOI - PubMed
    1. Townsend D. and Tew K. (2003) Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am. J. Pharmacogenomics 3, 157–172 10.2165/00129785-200303030-00002 - DOI - PMC - PubMed
    1. Lalle M., et al. (2015) The FAD-dependent glycerol-3-phosphate dehydrogenase of Giardia duodenalis: an unconventional enzyme that interacts with the g14-3-3 and it is a target of the antitumoral compound NBDHEX. Front. Microbiol. 6, 544 10.3389/fmicb.2015.00544 - DOI - PMC - PubMed

Publication types

MeSH terms